Skip to main content
SpringerLink
Log in

Genetic Engineering Applied to the Development of Vaccines

  • Chapter
Protein Production by Biotechnology

  • 179 Accesses

Abstract

Man and other animals survive the relentless assault of a large array of microbial pathogens because they have evolved mechanisms that enable them not only to recover from initial attacks and purge themselves of the offender, but also to remember sufficient information about the molecular morphology of an individual aggressor that they are able to repulse further intrusions very quickly and effectively. Through this combination of exposure to a pathogen and clearance and recollection of it, the animal becomes immune to that particular pathogen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Szmuness, W., Stevens, C. E., Harley, E. J., Zang, E. A., Oleszko, W. R., William, D. C. et al., Hepatitis B vaccine. Demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. New Engl. J. Med., 203 (1980) 833–41.

    Article  Google Scholar 

  2. Murray, K., Genetic engineering: possibilities and prospects for its application in industrial microbiology. Phil Trans. R. Soc. Lond., B 290 (1980) 369–86.

    Article  CAS  Google Scholar 

  3. Evans, D.M.A., Dunn, G., Minor, P. D., Schild, G.C., Cann, A. J., Stanway, G., Almond, J. W., Currey, K. & Maizel, J. V. Jr, Increased neurovirulence associated with a single nucleotide change in a monocoding region of the Sabin type 3 poliovaccine genome. Nature, Lond., 314 (1985) 548–50.

    Article  CAS  Google Scholar 

  4. Dane, D. S., Cameron, C. H. & Briggs, M., Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet, i (1970) 695-8.

    Article  Google Scholar 

  5. Vyas, G. N., Cohen, S. N. & Schmid, R. (eds), Viral Hepatitis. Franklin Institute Press, Philadelphia, 1978.

    Google Scholar 

  6. Szmuness, W., Alter, H. J. & Maynard, J. E. (eds), Viral Hepatitis 1981. International Symposium. Franklin Institute Press, Philadelphia, 1982.

    Google Scholar 

  7. Vyas, G. N., Dienstag, J. L. & Hoofnagle, J. H. (eds), Viral Hepatitis and Liver Disease. Grune & Stratton, Orlando, Florida, 1984.

    Google Scholar 

  8. Murray, K., The Leeuwenhoek Lecture, 1985. A molecular biologist’s view of viral hepatitis. Proc. R. Soc. Lond., B 230 (1987) 107–46.

    Article  PubMed  CAS  Google Scholar 

  9. Ganem, D. & Varmus, H. E., The molecular biology of the hepatitis B viruses. Ann. Rev. Biochem., 56 (1987) 651–93.

    Article  PubMed  CAS  Google Scholar 

  10. Zuckerman, A J. (ed.), Viral Hepatitis and Liver Disease. Alan R. Liss, New York, 1988.

    Google Scholar 

  11. Heermann, K. H., Goldmann, U., Schwartz, W., Seyffarth, T., Baumgarten, H. & Gerlich, W. H., Large surface proteins of hepatitis B virus containing the pre-S sequence. J. Virol., 52 (1984) 396–402.

    PubMed  CAS  Google Scholar 

  12. Mackay, P., Lees, J. & Murray, K., The conversion of hepatitis B core antigen synthesised in E. coli into e antigen. J. Med. Virol., 8 (1981) 237–41.

    Article  PubMed  CAS  Google Scholar 

  13. Sureau, G, Romet-Lemmone, J. L., Millins, J. I. & Essex, M., Production of hepatitis B virus by a differentiated human hepatoma cell line after transformation with cloned circular HBV DNA. Cell, 47 (1986) 37–47.

    Article  PubMed  CAS  Google Scholar 

  14. Broome, S. & Gilbert, W., Immunological screening method to detect specific translation products. Proc. Nat. Acad. Sci., USA, 75 (1978) 2746–9.

    Article  CAS  Google Scholar 

  15. Burrell, G J., MacKay, P., Greenaway, P. J., Hofschneider, P.-H. & Murray, K., Expression in Escherichia coli of hepatitis B virus DNA sequences cloned in Plasmid pBR322. Nature, Lond., 279 (1979) 43–7.

    Article  CAS  Google Scholar 

  16. Pasek, M., Goto, T., Gilbert, W., Zink, D., Schaller, H., MacKay, P., Leadbetter, G. & Murray, K., Hepatitis B virus genes and their expression in Escherichia coli. Nature, Lond., 282 (1979) 575–9.

    Article  CAS  Google Scholar 

  17. Pugh, J. G., Weber, G., Houston, H. & Murray, K., Expression of the X gene of hepatitis B virus. J. Med. Virol., 20 (1986) 229–46.

    Article  PubMed  CAS  Google Scholar 

  18. Cohen, B. J. & Richmond, J. E., Electron microscopy of hepatitis B core antigen synthesised in E. coli. Nature, Lond., 296 (1987) 667–8.

    Google Scholar 

  19. Stahl, S., MacKay, P., Magazin, M., Bruce, S. A. & Murray, K., Hepatitis B virus core antigen: its synthesis in Escherichia coli and application in diagnosis. Proc. Nat. Acad. Sci., USA, 79 (1982) 1606–10.

    Article  CAS  Google Scholar 

  20. Koziol, D. E., Holland, P. V., Ailing, D. W., Melpolder, J. G., Solomon, R. E., Purcell, R. H., Hudson, L. M., Shoup, F. J., Krakauer, H. & Alter, H. J., Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann. Int. Med., 104 (1986) 488–95.

    PubMed  CAS  Google Scholar 

  21. MacKay, P., Pasek, M., Magazin, M., Kovacic, R. T., Allet, B., Stahl, S. et al., Production of immunologically active surface antigens of hepatitis B virus by Escherichia coli. Proc. Nat. Acad. Sci., USA, 78 (1981) 4510–14.

    Article  CAS  Google Scholar 

  22. Valenzuela, P., Medina, A, Rutter, W. J., Ammerer, G & Hall, B. D., Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature, Lond., 298 (1982) 347–50.

    Article  CAS  Google Scholar 

  23. Miyanohara, A, Toh, E.-A., Nozaki, G., Hamada, F., Ohtomo, N. & Matsubara, K., Expression of hepatitis B surface antigen in yeast. Proc. Nat. Acad. Sci., USA, 80 (1983) 1–5.

    Article  CAS  Google Scholar 

  24. Murray, K., Bruce, S. A, Hinnen, A, Wingfield, P., van erd, P. M. G A., de Reus, A. & Schellekens, H., Hepatitis B virus antigens made in microbial cells immunise against viral infection. EMBO J., 3 (1984) 645–50.

    PubMed  CAS  Google Scholar 

  25. Davidson, M. & Krugman, S., Immunogenicity of recombinant yeast hepatitis B vaccine. Lancet, i (1985) 108–9.

    Article  Google Scholar 

  26. Ichida, F., Yoshikawa, A., Mizokami, M., Yamamoto, M., Inaba, N., Takamizawa, H., Ohmura, T., Ohmizu, A., Ohata, J., Uemura, Y. & Nishida, M., Clinical study of recombinant hepatitis B vaccine. J. Int. Med. Res., 16(1988) 231–6.

    PubMed  CAS  Google Scholar 

  27. Neurath, A. R., Kent, S. B. H., Strick, N., Taylor, P. & Stevens, G E., Hepatitis B virus contains pre-S gene-encoded domains. Nature, Lond., 315 (1985) 154–6.

    Article  CAS  Google Scholar 

  28. Vento, S., Hegarty, J. E., Alberti, A., O’Brien, G J., Alexander, G. J. M., Eddleston, A L. W. F. & Williams, R., T lymphocyte sensitization to HBcAg and T cell-mediated unresponsiveness to HBsAg in hepatitis B virus-related chronic liver disease. Hepatology, 5 (1983) 192–7.

    Article  Google Scholar 

  29. Murray, K., Bruce, S. A., Wingfield, P., van Eerd, P., de Reus, A. & Schellekens, H., Protective immunisation against hepatitis B with an internal antigen of the virus. J. Med. Virol., 23 (1987) 101–7.

    Article  PubMed  CAS  Google Scholar 

  30. Iwarson, S., Tabor, E., Thomas, H. C., Snoy, P. & Gerety, R. J., Protection against hepatitis B virus infection by immunization with hepatitis B core antigen. Gastroenterology, 88 (1985) 763–7.

    PubMed  CAS  Google Scholar 

  31. McGlynn, E. & Murray, K., Hepatitis B virus polymerase: expression of its gene in Escherichia coli and detection of antibodies to the product in convalescent sera. In Viral Hepatitis and Liver Disease, ed. A. J. Zuckerman. Alan R. Liss, New York, 1988, pp. 323–9.

    Google Scholar 

  32. Murray, K., Application of recombinant DNA techniques in the development of viral vaccines. Vaccine, 6 (1988) 164–74.

    Article  PubMed  CAS  Google Scholar 

  33. Milich, D. R., McLachlan, A, Moriarty, A. & Thornton, G. B., Immune response to hepatitis B virus core antigen (HBcAg): localization of T cell recognition sites within HBcAg/HBeAg. J. Immunol., 139 (1987) 1223–31.

    PubMed  CAS  Google Scholar 

  34. Milich, D. R, McLachlan, A, Thornton, G. B. & Hughes, J. L., Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site. Nature, Lond., 329 (1987) 547–9.

    Article  CAS  Google Scholar 

  35. Kennedy, R. C., Kenkel, R. D., Pauletti, D., Allan, J. S., Lee, T. H., Essex, M. & Dreesman, G. R., Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein. Science, Wash., 231 (1986) 1556–9.

    Article  CAS  Google Scholar 

  36. Chanh, T. C., Dreesman, G. R., Kanda, P., Linette, G. P., Sparrow, J. T., Ho, D. D. & Kennedy, R. C, Induction of anti-HIV neutralizing antibodies by synthetic peptides. EMBO J., 5 (1986) 3065–71.

    PubMed  CAS  Google Scholar 

  37. Dalgleish, A. G., Chanh, T. C., Kennedy, R. C., Kanda, P., Clapham, P. R & Weiss, R. A, Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against a gp41 synthetic peptide. Virology, 165 (1988) 209–15.

    Article  PubMed  CAS  Google Scholar 

  38. Clarke, B. E., Newton, S. E., Carroll, A. R., Francis, M. J. et al., Greatly improved immunogenicity of a peptide epitope by fusion of hepatitis B core protein. Nature, Lond., 330 (1987) 381–3.

    Article  CAS  Google Scholar 

  39. Le Bouvier, G. L., The heterogeneity of Australia antigen. J. Infect. Dis., 123 (1971) 671–5.

    Article  PubMed  Google Scholar 

  40. Bancroft, W. H., Mundan, F. K & Russell, P. K., Detection of additional antigenic determinants of hepatitis B antigen. J. Immunol., 109 (1972) 842–8.

    PubMed  CAS  Google Scholar 

  41. Murphy, B. L., Maynard, J. E. & Le Bouvier, G. L., Viral subtypes and cross-protection in hepatitis B virus infection of chimpanzees. Intervirology, 3 (1974) 378–81.

    Article  PubMed  CAS  Google Scholar 

  42. McAuliffe, V. J., Purcell, R. H. & Gerin, J. L., Type-B hepatitis — a review of current prospects for a safe and effective vaccine. Rev. Infect. Dis., 2 (1980) 470–92.

    Article  PubMed  CAS  Google Scholar 

  43. Benjamin, D. C., Berzofsky, J. A, East, I. J., Gurd, F. R N., Hannum, C., Leach, S. J., Margoliash, E., Michael J. G., Miller, A, Prager, E. M., Reichlin, M., Sercarz, E. E., Smith-Gill, S. J., Todd, P. E. & Wilson, A. C., The antigenic structure of proteins: an appraisal. Ann. Rev. Immunol., 2 (1984) 67–101.

    Article  CAS  Google Scholar 

  44. Dreesman, G. R., Hollinger, R. B., MacCombs, R. M. & Melnick, J. L., Alteration of HBsAg determinants by reduction and alkylation. J. Gen. Virol., 19 (1973) 129–34.

    Article  PubMed  CAS  Google Scholar 

  45. Sukeno, N., Shirachi, R., Yamaguchi, N. & Ishida, N., Reduction and reoxidation of Australia antigen: loss and reconstitution of particle structure and antigenicity. J. Virol., 9 (1972) 182–3.

    PubMed  CAS  Google Scholar 

  46. Vyas, G. N., Rao, K. R. & Ibrahim, A. B., Australia antigen (hepatitis B antigen). A conformation antigen dependent on disulphide bonds. Science, Wash., 178 (1972) 1300–1.

    Article  CAS  Google Scholar 

  47. Swenson, P. D., Peterson, D. L. & Hu, P. S., Antigenic analysis of HBsAg with monoclonal antibodies specific for S-protein and pre-S2 sequences. In Viral Hepatitis and Liver Disease, ed. A. J. Zuckerman. Alan R. Liss, New York, 1988, pp. 627–31.

    Google Scholar 

  48. Tedder, R. S., Yao, J. L. & Ferns, R. B., Generation of oligonucleotide-directed mutations using phosphorothioate-DNA. Nucl. Acids Res. Commun., 13 (1984) 8765–85.

    Google Scholar 

  49. Wiktor, T. J., MacFarlan, R. I., Reagan, K. J., Dietzschold, B., Curtis, P. J., Wunner, W. H., Kieny, M.-P., Lathe, R., Lecocq, J.-P., Mackett, M, Moss, B. & Koprowski, H., Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proc. Nat. Acad. Sci., USA, 81 (1984) 7194–8.

    Article  CAS  Google Scholar 

  50. Gerin, J. L., Alexander, H., Shih, J. W.-K., Purcell, R. H., Dapolito, G., Engle, R., Green, N., Sutcliffe, J. G., Shinnick, T. M. & Lerner, R. A., Chemically synthesised peptides of hepatitis B surface antigen duplicate the d/y subtype specificities and induced subtype specific antibodies in chimpanzees. Proc. Nat. Acad. Sci., USA, 80 (1983) 2365–9.

    Article  CAS  Google Scholar 

  51. Hopp, T. P. & Woods, K. R., Prediction of protein antigenic determinants from amino acid sequences. Proc. Nat. Acad. Sci., USA, 78 (1981) 3824-8.

    Article  CAS  Google Scholar 

  52. Prince, A. M., Ikram, H. & Hopp, T. P., Hepatitis B virus vaccine: Identification of HBsAg/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immunogenic peptide. Proc. Nat. Acad. Sci., USA, 79 (1982) 579–82.

    Article  CAS  Google Scholar 

  53. Dreesman, G. R., Sanchez, Y., Ionescu-Matiu, I., Sparrow, J. T., Six, H. R., Peterson, D. L., Hollinger, F. B. & Melnick, J. L., Antibody to HBsAg after a single inoculation of uncoupled synthetic HBsAg peptide. Nature, Lond., 295 (1982) 158–60.

    Article  CAS  Google Scholar 

  54. Bhatnagar, P. K., Papas, E., Blum, H. E., Milich, D. R., Nitecki, D., Karels, M. J. & Vyas, G. N., Immune response to synthetic peptide analogues of hepatitis B surface antigen for the a determinant. Proc Nat. Acad. Sci., USA, 79 (1982) 4400–4.

    Article  CAS  Google Scholar 

  55. Brown, S. E., Howard, C. R., Zuckerman, A. J. & Steward, M. W., Determination of the affinity of antibodies to hepatitis B surface antigen in human sera. J. Immunol. Methods, 72 (1984) 41–8.

    Article  PubMed  CAS  Google Scholar 

  56. Antoni, B. A. & Peterson, D. L., Site-directed mutagenesis of the hepatitis B surface antigen gene: creation of a free sulphydryl group and modification of the protein in the 22 nm particle structure. In Viral Hepatitis and Liver Disease, ed. A. J. Zuckerman. Alan R. Liss, New York, 1988, pp. 313–17.

    Google Scholar 

  57. Stahl, S. & Murray, K., Immunogenicity of peptide fusions to hepatitis B virus core antigen. Proc. Natl. Acad. Sci. USA, 86 (1989) 6283–7.

    Article  PubMed  CAS  Google Scholar 

  58. Ashton-Rickardt, P. G. & Murray, K., Mutants of the hepatitis B virus surface antigen that define antigenically essential residues in the immunodominant a region. J. Med. Virol. (in press).

    Google Scholar 

  59. Ashton-Rickardt, P. G. & Murray, K., Mutations that change the immunological subtype of hepatitis B virus surface antigen and distinguish between antigenic and immunogenic determination. J. Med. Virol. (in press).

    Google Scholar 

  60. Lindberg, A. A, Norby, E. & Wigzell, H., The vaccines of the future. Vaccine, 6 (1988) 73–250.

    Google Scholar 

Download references

Author information

Author notes

  1. S. Stahl

    Present address: Nationnal Institutes of Health, Bethesda, Maryland, USA

  2. P. G. Ashton-Rickardt

    Present address: Department of Pathology, University of Edinburgh Medical School, Edinburgh, UK

Authors and Affiliations

  1. Department of Molecular Biology, University of Edinburgh, Edinburgh, UK

    K. Murray & P. G. Ashton-Rickardt

  2. Biogen S.A., Geneva, Switzerland

    S. Stahl

Authors
  1. K. Murray
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Stahl
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. G. Ashton-Rickardt
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Glaxo Group Research Limited, Greenford Road, Greenford, Middlesex, UB6 OHE, UK

    T. J. R. Harris (Director of Biotechnology) (Director of Biotechnology)

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Elsevier Science Publishers Ltd

About this chapter

Cite this chapter

Murray, K., Stahl, S., Ashton-Rickardt, P.G. (1990). Genetic Engineering Applied to the Development of Vaccines. In: Harris, T.J.R. (eds) Protein Production by Biotechnology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1565-0_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-1565-0_3

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8858-9

  • Online ISBN: 978-1-4613-1565-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation